A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
about
P1343
Exon shuffling in vivo can generate novel HLA class I moleculesQuantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramersHuman immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity.Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.Rapid and sensitive identification of major histocompatibility complex class I-associated tumor peptides by Nano-LC MALDI MS/MS.Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia.Identifying source proteins for MHC class I-presented peptides.Human heat shock protein 70 enhances tumor antigen presentation through complex formation and intracellular antigen delivery without innate immune signaling.An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.Ischemia/reperfusion injury in human kidney transplantation: an immunohistochemical analysis of changes after reperfusion.Early region 3 of adenovirus type 19 (subgroup D) encodes an HLA-binding protein distinct from that of subgroups B and CAn immunohistological study of HLA antigen expression by gestational choriocarcinoma.Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones.Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.Total chemical synthesis, characterization, and immunological properties of an MHC class I model using the TASP concept for protein de novo design.Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.HLA antigen structural gene mutants selected with an allospecific monoclonal antibody.HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant.Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants.Epstein-Barr virus-specific cytotoxic T lymphocytes as probes of HLA polymorphism. Heterogeneity of T cell-restricting determinants associated with the serologically defined HLA-A2 antigen.Evidence of widespread binding of HLA class I molecules to peptides.Analysis of T cell signaling by class I MHC molecules: the cytoplasmic domain is not required for signal transductionExpression and function of CD8 in a murine T cell hybridoma.Rescue of Daudi cell HLA expression by transfection of the mouse beta 2-microglobulin gene.Direct evidence for binding of CD8 to HLA class I antigens.Lysis of human melanoma cells by autologous cytolytic T cell clones. Identification of human histocompatibility leukocyte antigen A2 as a restriction element for three different antigens.Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes.Interaction between CD8 and major histocompatibility complex (MHC) class I mediated by multiple contact surfaces that include the alpha 2 and alpha 3 domains of MHC class I.A mutated HLA-A2 molecule recognized by autologous cytotoxic T lymphocytes on a human renal cell carcinoma.Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.Allele-specific B pocket transplant in class I major histocompatibility complex protein changes requirement for anchor residue at P2 of peptide.Expression of class I and II major histocompatibility complex antigens in Wilms' tumour and normal developing human kidney.Quantitative correlation between HLA class I allele expression and recognition of melanoma cells by antigen-specific cytotoxic T lymphocytes.Transcription analysis, physical mapping, and molecular characterization of a nonclassical human leukocyte antigen class I geneDirect binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I moleculesAmino acid sequences in the alpha 1 domain and not glycosylation are important in HLA-A2/beta 2-microglobulin association and cell surface expressionStructural identity of human histocompatibility leukocyte antigen-B27 molecules from patients with ankylosing spondylitis and normal individualsDistribution of HLA class 1 antigens in normal human tissue and in mammary cancer.
P2860
Q24555794-15041085-CE5F-4BE9-A47D-77D913B3DC9EQ27485114-AFAC99A5-464D-4ED3-AAA9-3BADFC282AEFQ30312050-05A75F89-0E70-40D7-B579-6A1167B96475Q30442878-1BAA1695-C6E0-48FD-A345-DDC00AF8D40EQ33222048-2569D3C2-4EEA-4FB5-A88C-5DB852FA9A65Q33893109-BAB4DA39-D082-4EAD-A1CD-508C4D565C29Q34292047-5D6FCB8E-34CF-4CF6-9FAE-666BB45D3391Q34553385-5E6FF624-31A8-4236-93EC-83BF03E81E23Q34660530-3580EDAD-5D25-4AB3-B42E-9BEB98AD6421Q34923734-E9A7FD21-0594-40AB-B74A-727D2EF5AE32Q35699002-4EB29AB4-0DFA-43BB-80FF-ACDE035730F9Q35753256-6032918E-B4B3-40B7-8A4B-ADB894F6F6BCQ35859922-5F1BCADD-0AB0-4225-8ED5-E3A3078E0D6EQ35992228-F039667E-B41E-47EA-BD01-AE88573B22E0Q36067021-797BAD35-FFE3-4D62-A107-985FF7D8E904Q36134480-C4ED6A42-36C1-4428-B6A0-F3FFFFA2CEC4Q36277371-2A340E52-0542-4D60-980A-C5991E02D84CQ36300255-43B32629-B766-4F5D-BA4B-B26DFEBF30D1Q36327363-07EE7132-F831-4AD9-AD16-C799C11C6961Q36347388-DC5B5343-1F4C-4686-BEC7-64C660D10812Q36348326-38B06325-241C-4F5F-8B72-D5C2F94D6EECQ36348956-B31F0DFD-C9CD-4D7D-A976-1A778EA787C8Q36353424-25FDC98C-5802-49E6-8498-CB73D5784E1BQ36353628-0EC68A43-8C7E-4057-89A9-E9917BA1FA2FQ36354243-27679957-E7B0-40A6-892F-657698159700Q36354485-7A5ADC1C-EB39-4A3B-BFBB-0D8B62F83999Q36355855-E8024A11-21C9-410C-BA7A-C9031A8C995EQ36356745-AA252B51-9A61-4AFB-BE99-2D2CABC52100Q36364266-81DF4E74-4C34-46E8-9247-AED298AE14A1Q36365379-4A1A6943-35C0-4C5F-960A-01876EEE9589Q36366872-9CDD3464-DDCC-439A-9D8B-F88C9B7E994DQ36375095-6AF34AC2-9635-45BE-89FF-55F1BDC7174FQ36437335-FD79D80C-5537-4D9A-912B-82EF293C3BBCQ36466840-8878BD3B-33B8-426B-A758-05FE5F6C137AQ36470734-C74BB108-6C00-4AE7-8F2A-69F0B83B4C5DQ36713701-89A69976-DC96-4783-AD43-A7DDD7AC9362Q36736384-48E53993-5D9E-4528-8FF6-652681758EA2Q36836449-B6C8FC34-C61B-49BE-A2B0-3D307EF2A37BQ37007857-971652C9-26F8-405B-A84A-4A245D13DBD4Q37078568-ED6645F6-C97E-484A-92A1-E6B47EC168CF
P2860
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh-hant
name
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@en
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@nl
type
label
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@en
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@nl
prefLabel
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@en
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@nl
P2093
P1433
P1476
A monoclonal antibody that recognizes an antigenic determinant shared by HLA A2 and B17.
@en
P2093
P304
P356
10.1016/0198-8859(80)90099-3
P4510
P577
1980-09-01T00:00:00Z